Validation and Reliability of a Disease-Specific Quality of Life Measure in Patients with Cutaneous Lupus Erythematosus: CLEQoL.

CONCLUSION: The CLEQoL was found to be a valid and reliable PRO measure for assessing QoL in patients with CLE. Demonstrating that the CLEQoL has strong psychometric properties is an important step towards the development of a disease-specific PRO measure that future clinical trials can use. This article is protected by copyright. All rights reserved. PMID: 30637718 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/30637718?dopt=Abstract

Source: The British Journal of Dermatology - January 13, 2019 Category: Dermatology Authors: Ogunsanya ME, Cho SK, Hudson A, Chong BF Tags: Br J Dermatol Source Type: research